New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Total court-issued penalties for breaches higher than any other crime bar motoring offences and TV licence evasion
Simon Case tells inquiry it was ‘very frustrating’ to work for Boris Johnson during Covid crisis
As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease
Calls for amnesty intensify as total guilty verdicts over pandemic regulations in England top 27,000
So-called FLiRT strains set to test effectiveness of vaccines against latest mutations
Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals
GSK joins UK government in committing £130mn to tackle growth of antimicrobial resistance
Businesses across hospitality sector have brought dozens of cases in bid to recover some losses
Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients
More large-scale investment programmes are possible despite the mixed results of Europe’s post-pandemic plan
Agreement worth up to $1.2bn includes plan for combined flu and Covid shots
Saving humanity’s a costly business
Also in this newsletter: UK expels Russian defence attaché for spying, Toyota profits drop 20%, regulatory costs hit Uber
Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab
Top 50 biggest stock gainers hit by painful decrease since the end of 2020 as lockdown trends fade
Experts warn better data is required to drive policy as debilitating condition reduces workforce
Europe may be the fastest-warming continent, but its politicians are finding that climate regulations are a hard sell. This annual FT-Statista survey lists the companies that have made the most progress in cutting their carbon emissions intensity
Xi Jinping hopes manufacturing can offset the property slump
Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
Pledges to invest in pandemic preparedness with facility in Kenya fall short as sales of Covid jabs decline